Duration of mucositis and dysphagia following radiotherapy (+cetuximab) for locoregionally advanced head and neck cancer

被引:0
|
作者
Bonner, J. A.
Harari, P. M.
Giralt, J.
Raben, D.
Jassem, J.
Azarnia, N.
Spencer, S. A.
Rowinsky, E. K.
Amellal, N.
Baselga, J. L.
Ang, K.
机构
[1] Univ Alabama, Birmingham, AL USA
[2] Univ Wisconsin, Madison, WI USA
[3] Hosp Gen Valle Hebron, Barcelona, Spain
[4] Univ Colorado, Aurora, CO USA
[5] Med Univ Gdansk, Gdansk, Poland
[6] ImClone Syst, Branchburg, NJ USA
[7] Merck Lipha Sante France, Paris, France
[8] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
关键词
D O I
10.1016/j.ijrobp.2007.06.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4
引用
收藏
页码:S137 / S137
页数:1
相关论文
共 50 条
  • [41] Manageable Early Toxicity of Cetuximab Concurrent with Radical Radiotherapy for Locally Advanced Head and Neck Cancer
    Wieczorek, A.
    Hamid, A.
    O'Toole, L.
    [J]. CLINICAL ONCOLOGY, 2011, 23 (07) : 496 - 496
  • [42] Radiotherapy with Durvalumab vs. Cetuximab in Patients with Locoregionally Advanced Head and Neck Cancer and a Contraindication to Cisplatin: Phase II Results of NRG-HN004
    Mell, L. K.
    Torres-Saavedra, P.
    Wong, S.
    Chang, S.
    Kish, J. A.
    Minn, A. J., III
    Jordan, R.
    Liu, T.
    Truong, M. T.
    Winquist, E.
    Wise-Draper, T.
    Rodriguez, C. P.
    Musaddiq, A.
    Beadle, B. M.
    Henson, C.
    Narayan, S.
    Spencer, S. A.
    Harris, J.
    Yom, S. S.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (05): : 1058 - 1058
  • [43] Concomitant hyperfractionated accelerated radiotherapy (HART) with cisplatin and concurrent cetuximab for locoregionally advanced squamous cell head and neck cancer: a phase I dose escalation trial
    Kuhnt, T.
    Sandner, A.
    Wendt, T. G.
    Engenhardt-Cabillic, R.
    Lammering, G.
    Flentje, M.
    Grabenbauer, G. G.
    Pirnasch, A.
    Baumann, M.
    Dunst, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [44] EVALUATION OF TOXICITY WITH CONCURRENT CETUXIMAB AND RADIOTHERAPY IN HEAD AND NECK CANCER
    Carmona Vigo, R.
    Casanova Garcia, M. A.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2011, 98 : S21 - S21
  • [45] Enhanced toxicity with concurrent cetuximab and radiotherapy in head and neck cancer
    Pryor, David I.
    Porceddu, Sandro V.
    Burmeister, Bryan H.
    Guminski, Alex
    Thomson, Damien B.
    Shepherdson, Kristine
    Poulsen, Michael
    [J]. RADIOTHERAPY AND ONCOLOGY, 2009, 90 (02) : 172 - 176
  • [46] Induction Docetaxel, Cisplatin, and Cetuximab Followed by Concurrent Radiotherapy, Cisplatin, and Cetuximab and Maintenance Cetuximab in Patients With Locally Advanced Head and Neck Cancer
    Argiris, Athanassios
    Heron, Dwight E.
    Smith, Ryan P.
    Kim, Seungwon
    Gibson, Michael K.
    Lai, Stephen Y.
    Branstetter, Barton F.
    Posluszny, Donna M.
    Wang, Lin
    Seethala, Raja R.
    Dacic, Sanja
    Gooding, William
    Grandis, Jennifer R.
    Johnson, Jonas T.
    Ferris, Robert L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (36) : 5294 - 5300
  • [47] Combined-modality therapy for locoregionally advanced head and neck cancer
    Cmelak, AJ
    Murphy, BA
    Day, T
    [J]. ONCOLOGY-NEW YORK, 1999, 13 (10): : 83 - 91
  • [48] OPTIMIZATION OF COMBINED MODALITY THERAPY FOR LOCOREGIONALLY ADVANCED HEAD AND NECK CANCER
    Vokes, E. E.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 36 - 36
  • [49] Simultaneous Integrated Boost Intensity Modulated Radiotherapy in the Inoperable Locoregionally Advanced Head and Neck Cancer: Clinical Results
    Dzhugashvili, M.
    Escolar-Perez, P.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S475 - S475
  • [50] CLINICAL PRACTICE GUIDANCE FOR RADIOTHERAPY PLANNING AFTER INDUCTION CHEMOTHERAPY IN LOCOREGIONALLY ADVANCED HEAD-AND-NECK CANCER
    Salama, Joseph K.
    Haddad, Robert I.
    Kies, Merril S.
    Busse, Paul M.
    Dong, Lei
    Brizel, David M.
    Eisbruch, Avraham
    Tishler, Roy B.
    Trotti, Andy M.
    Garden, Adam S.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : 725 - 733